Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms

Abstract Migraine is a common, polygenic disorder that is characterized by moderate to severe headache attacks. Migraine attacks are commonly treated with triptans, i.e. serotonin receptor agonists. However, triptans are effective in ~ 60% of the population, and the mechanisms of triptans are debate...

Full description

Bibliographic Details
Main Authors: Lisette J. A. Kogelman, Katrine Falkenberg, Filip Ottosson, Madeleine Ernst, Francesco Russo, Valdemar Stentoft-Hansen, Samuel Demharter, Peer Tfelt-Hansen, Arieh S. Cohen, Jes Olesen, Thomas Folkmann Hansen
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-38904-1
_version_ 1797752738064367616
author Lisette J. A. Kogelman
Katrine Falkenberg
Filip Ottosson
Madeleine Ernst
Francesco Russo
Valdemar Stentoft-Hansen
Samuel Demharter
Peer Tfelt-Hansen
Arieh S. Cohen
Jes Olesen
Thomas Folkmann Hansen
author_facet Lisette J. A. Kogelman
Katrine Falkenberg
Filip Ottosson
Madeleine Ernst
Francesco Russo
Valdemar Stentoft-Hansen
Samuel Demharter
Peer Tfelt-Hansen
Arieh S. Cohen
Jes Olesen
Thomas Folkmann Hansen
author_sort Lisette J. A. Kogelman
collection DOAJ
description Abstract Migraine is a common, polygenic disorder that is characterized by moderate to severe headache attacks. Migraine attacks are commonly treated with triptans, i.e. serotonin receptor agonists. However, triptans are effective in ~ 60% of the population, and the mechanisms of triptans are debated. Here, we aim to expose the mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks. We collected temporal multi-omics profiles on 24 migraine patients, using samples collected at a migraine attack, 2 h after treatment with a triptan, when headache-free, and after a cold-pressor test. Differential metabolomic analysis was performed to find metabolites associated with treatment. Their effect was further investigated using correlation analysis and a machine learning approach. We found three differential metabolites: cortisol, sumatriptan and glutamine. The change in sumatriptan levels correlated with a change in GNAI1 and VIPR2 gene expression, both known to regulate cAMP levels. Furthermore, we found fatty acid oxidation to be affected, a mechanism known to be involved in migraine but not previously found in relation to triptans. In conclusion, using an integrative approach we find evidence for a role of glutamine, cAMP regulation, and fatty acid oxidation in the molecular mechanisms of migraine and/or the effect of triptans.
first_indexed 2024-03-12T17:08:51Z
format Article
id doaj.art-019b32d50c554687bdf123c45787a1b2
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-12T17:08:51Z
publishDate 2023-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-019b32d50c554687bdf123c45787a1b22023-08-06T11:11:50ZengNature PortfolioScientific Reports2045-23222023-07-011311810.1038/s41598-023-38904-1Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanismsLisette J. A. Kogelman0Katrine Falkenberg1Filip Ottosson2Madeleine Ernst3Francesco Russo4Valdemar Stentoft-Hansen5Samuel Demharter6Peer Tfelt-Hansen7Arieh S. Cohen8Jes Olesen9Thomas Folkmann Hansen10Department of Neurology, Danish Headache Center, Copenhagen University HospitalDepartment of Neurology, Danish Headache Center, Copenhagen University HospitalDepartment of Congenital Disorders, Section for Clinical Mass Spectrometry, Danish Center for Neonatal Screening, Statens Serum InstitutDepartment of Congenital Disorders, Section for Clinical Mass Spectrometry, Danish Center for Neonatal Screening, Statens Serum InstitutDepartment of Congenital Disorders, Section for Clinical Mass Spectrometry, Danish Center for Neonatal Screening, Statens Serum InstitutAbzu ApSAbzu ApSDepartment of Neurology, Danish Headache Center, Copenhagen University HospitalDepartment of Congenital Disorders, Section for Clinical Mass Spectrometry, Danish Center for Neonatal Screening, Statens Serum InstitutDepartment of Neurology, Danish Headache Center, Copenhagen University HospitalDepartment of Neurology, Danish Headache Center, Copenhagen University HospitalAbstract Migraine is a common, polygenic disorder that is characterized by moderate to severe headache attacks. Migraine attacks are commonly treated with triptans, i.e. serotonin receptor agonists. However, triptans are effective in ~ 60% of the population, and the mechanisms of triptans are debated. Here, we aim to expose the mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks. We collected temporal multi-omics profiles on 24 migraine patients, using samples collected at a migraine attack, 2 h after treatment with a triptan, when headache-free, and after a cold-pressor test. Differential metabolomic analysis was performed to find metabolites associated with treatment. Their effect was further investigated using correlation analysis and a machine learning approach. We found three differential metabolites: cortisol, sumatriptan and glutamine. The change in sumatriptan levels correlated with a change in GNAI1 and VIPR2 gene expression, both known to regulate cAMP levels. Furthermore, we found fatty acid oxidation to be affected, a mechanism known to be involved in migraine but not previously found in relation to triptans. In conclusion, using an integrative approach we find evidence for a role of glutamine, cAMP regulation, and fatty acid oxidation in the molecular mechanisms of migraine and/or the effect of triptans.https://doi.org/10.1038/s41598-023-38904-1
spellingShingle Lisette J. A. Kogelman
Katrine Falkenberg
Filip Ottosson
Madeleine Ernst
Francesco Russo
Valdemar Stentoft-Hansen
Samuel Demharter
Peer Tfelt-Hansen
Arieh S. Cohen
Jes Olesen
Thomas Folkmann Hansen
Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
Scientific Reports
title Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
title_full Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
title_fullStr Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
title_full_unstemmed Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
title_short Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
title_sort multi omic analyses of triptan treated migraine attacks gives insight into molecular mechanisms
url https://doi.org/10.1038/s41598-023-38904-1
work_keys_str_mv AT lisettejakogelman multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT katrinefalkenberg multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT filipottosson multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT madeleineernst multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT francescorusso multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT valdemarstentofthansen multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT samueldemharter multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT peertfelthansen multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT ariehscohen multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT jesolesen multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms
AT thomasfolkmannhansen multiomicanalysesoftriptantreatedmigraineattacksgivesinsightintomolecularmechanisms